Ovarian Cancer Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceSupports immune function; low levels associated with poorer outcomes
Supporting Studies (1)
Anti-inflammatory; supports immune function; may help with cachexia
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory and antioxidant; being studied as adjunct therapy
Supporting Studies (1)
May support gut health during chemotherapy; reduce GI side effects
Supporting Studies (1)
Helps with chemotherapy-induced nausea
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Ovarian cancer is a serious cancer that begins in the ovaries. It often goes undetected until it has spread within the pelvis and abdomen, making it challenging to treat at advanced stages.
TYPES:
SYMPTOMS (often vague until advanced):
CRITICAL: Ovarian cancer requires comprehensive oncological care. This protocol is SUPPORTIVE ONLY and must be coordinated with your oncology team.
MEDICAL TREATMENTS:
GENETIC TESTING:
IMPORTANT CONSIDERATIONS:
* Vitamin D and omega-3 support overall health during treatment.
* Ginger can help with chemotherapy-induced nausea.
* Always clear supplements with oncology team.
Expected timeline: Treatment and prognosis depend on stage and type. Supplements provide supportive care during treatment journey.
Clinical Perspective
Ovarian Cancer: Epithelial most common (high-grade serous predominant). Risk factors: BRCA1/2 mutations, Lynch syndrome, family history, nulliparity. Staging is surgical. Treatment: primary debulking surgery + platinum/taxane chemotherapy. PARP inhibitors for maintenance (BRCA-mutated, HRD-positive).
CRITICAL: Supplements must be coordinated with oncology team - potential interactions with chemotherapy. Evidence for supplements in ovarian cancer is limited. Ginger has best evidence for chemo-induced nausea. Vitamin D optimization reasonable. High-dose antioxidants controversial during chemotherapy. Ketogenic diet being studied but not standard. Supportive care focus: nutrition, symptom management, quality of life.
* Vitamin D (C-grade): Immune support. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* Omega-3 (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Curcumin (C-grade): Research interest. Review: (PMID: 27213821). 1000-2000mg daily.
* Probiotics (C-grade): GI support. Systematic review: (PMID: 24045160). 10-20B CFU daily.
* Ginger (B-grade): Antiemetic. Systematic review: (PMID: 21818642). 1-2g daily.
Assessment targets: Response to treatment (CA-125, imaging), symptom control, quality of life, nutritional status.
Protocol notes: Supplements and chemo: always discuss with oncologist; some antioxidants controversial. Ginger: well-studied for CINV; can use with antiemetics. Vitamin D: optimize levels; deficiency common. BRCA testing: affects treatment (PARP inhibitors) and family screening. Nutrition: maintain adequate protein; address cachexia if present. CA-125: monitor during treatment; not for screening. Recurrence: common; maintenance therapy reduces risk. Integrative oncology: many cancer centers offer; coordinate care. Clinical trials: consider enrollment. Palliative care: early integration improves quality of life.